Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC.JUNS · Entity 8326 | Director · CEO and Chairman | June 02, 2026 | June 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
JUPITER NEUROSCIENCES, INC.
Report date June 02, 2026 · Filed June 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.28 · Expires 2036-06-02 | Direct | 747,783 |
Reported balance
After 2026-06-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-02 · Grant · Acquired 747,783 · Balance 747,783 F1: 747,783 options were granted under the Issuer's 2025 Equity Incentive Plan as a discretionary bonus for services rendered during fiscal 2025. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued employment through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: 747,783 options were granted under the Issuer's 2025 Equity Incentive Plan as a discretionary bonus for services rendered during fiscal 2025. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued employment through each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2026 Filed Jun 5, 2026 01:00 UTC | JUPITER NEUROSCIENCES, INC. JUNS · Entity 8326 | GrantStock Option · Derivative | 747,783 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0001493152-26-027365 · ownership.xml · derivative · entry 1 ROSEN CHRISTER · CIK 0000902453 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 747,783 Underlying: Common Stock · 747,783 shares Expires 2036-06-02 F1 · derivative.exercise_date: 747,783 options were granted under the Issuer's 2025 Equity Incentive Plan as a discretionary bonus for services rendered during fiscal 2025. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued employment through each vesting date. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 18:53 UTC | JUPITER NEUROSCIENCES, INC. JUNS · Entity 8326 | PurchaseCommon Stock | 3,100 | $1.02 | $3,162.00 |
DisclosureSEC source: 0001641172-25-017750 · ownership.xml · nonDerivative · entry 2 ROSEN CHRISTER · CIK 0000902453 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,078,892 Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 18:53 UTC | JUPITER NEUROSCIENCES, INC. JUNS · Entity 8326 | PurchaseCommon Stock | 500 | $1.01 | $505.00 |
DisclosureSEC source: 0001641172-25-017750 · ownership.xml · nonDerivative · entry 1 ROSEN CHRISTER · CIK 0000902453 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,075,792 Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 23:55 UTC | JUPITER NEUROSCIENCES, INC. JUNS · Entity 8326 | PurchaseCommon Stock | 1,000 | $1.05 | $1,050.00 |
DisclosureSEC source: 0001641172-25-017416 · ownership.xml · nonDerivative · entry 9 ROSEN CHRISTER · CIK 0000902453 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,075,292 Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 23:55 UTC | JUPITER NEUROSCIENCES, INC. JUNS · Entity 8326 | PurchaseCommon Stock | 1,500 | $1.04 | $1,560.00 |
DisclosureSEC source: 0001641172-25-017416 · ownership.xml · nonDerivative · entry 8 ROSEN CHRISTER · CIK 0000902453 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,074,292 Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 23:55 UTC | JUPITER NEUROSCIENCES, INC. JUNS · Entity 8326 | PurchaseCommon Stock | 700 | $1.03 | $721.00 |
DisclosureSEC source: 0001641172-25-017416 · ownership.xml · nonDerivative · entry 7 ROSEN CHRISTER · CIK 0000902453 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,072,792 Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 23:55 UTC | JUPITER NEUROSCIENCES, INC. JUNS · Entity 8326 | PurchaseCommon Stock | 1,450 | $1.02 | $1,479.00 |
DisclosureSEC source: 0001641172-25-017416 · ownership.xml · nonDerivative · entry 6 ROSEN CHRISTER · CIK 0000902453 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,072,092 Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 23:55 UTC | JUPITER NEUROSCIENCES, INC. JUNS · Entity 8326 | PurchaseCommon Stock | 2,000 | $1.01 | $2,020.00 |
DisclosureSEC source: 0001641172-25-017416 · ownership.xml · nonDerivative · entry 5 ROSEN CHRISTER · CIK 0000902453 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,070,642 Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 23:55 UTC | JUPITER NEUROSCIENCES, INC. JUNS · Entity 8326 | PurchaseCommon Stock | 1,000 | $0.98 | $980.00 |
DisclosureSEC source: 0001641172-25-017416 · ownership.xml · nonDerivative · entry 4 ROSEN CHRISTER · CIK 0000902453 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,068,642 Read SEC document |
| June 27, 2025 Filed Jul 1, 2025 23:55 UTC | JUPITER NEUROSCIENCES, INC. JUNS · Entity 8326 | PurchaseCommon Stock | 166 | $1.06 | $175.96 |
DisclosureSEC source: 0001641172-25-017416 · ownership.xml · nonDerivative · entry 3 ROSEN CHRISTER · CIK 0000902453 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,067,642 Read SEC document |
| June 02, 2025 Filed Jul 1, 2025 23:55 UTC | JUPITER NEUROSCIENCES, INC. JUNS · Entity 8326 | Exercise / conversionCommon Stock | 476,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-017416 · ownership.xml · nonDerivative · entry 2 ROSEN CHRISTER · CIK 0000902453 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,067,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents Restricted Stock Awards that vested upon expiration of the lock-up period. Read SEC document |
| June 02, 2025 Filed Jul 1, 2025 23:55 UTC | JUPITER NEUROSCIENCES, INC. JUNS · Entity 8326 | Exercise / conversionCommon Stock | 497,396 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-017416 · ownership.xml · nonDerivative · entry 1 ROSEN CHRISTER · CIK 0000902453 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,591,406 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents Restricted Stock Units that vested upon expiration of the lock-up period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.